Type: Public
On the web: http://www.baxter.com
Employees: 48,000
Employee growth: (3.4%)

Why choose between making drugs and making medical equipment when you can do both? Baxter International is one of those companies that has found a way to do it all by making a wide variety of medical products through three divisions. Its BioScience segment makes protein and plasma therapies to treat hemophilia and immune disorders, as well as vaccines and biological sealants used to close surgical wounds. Baxter is a leading maker of intravenous (IV) supplies and systems via its Medical Products segment; the segment also makes infusion pumps, prefilled syringes, and inhaled anesthetics. The division also makes dialyzers and other products for the treatment of end-stage renal disease (ESRD).

Key numbers for fiscal year ending December, 2011:
Sales: $13,893.0M
One year growth: 8.2%
Net income: $2,224.0M
Income growth: 56.6%

Officers:
Chairman and CEO: Robert L. Parkinson Jr.
Corporate VP, CFO, and Treasurer: Robert J. Hombach
Corporate VP and CIO: Paul E. Martin

Competitors:
Bayer HealthCare
CSL Behring
Grifols

© 2012 Hoover's, Inc. All rights reserved.